Xenon Pharmaceuticals Inc. (Nasdaq: XENE) plans to present six data sets at the 16th European Epilepsy Congress (EEC), scheduled for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE